1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Full-Life Acquires Focus-X

M&A Deal Summary

Full-Life Acquires Focus-X

On November 28, 2022, Full-Life acquired life science company Focus-X

Acquisition Highlights
  • This is Full-Life’s 1st transaction in the Life Science sector.
  • This is Full-Life’s 1st transaction in the United States.
  • This is Full-Life’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2022-11-28
Target Focus-X
Sector Life Science
Buyer(s) Full-Life
Deal Type Add-on Acquisition

Target

Focus-X

Watchung, New Jersey, United States
Focus-X is a preclinical-stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals. Focus-X was founded in 2020 and is based in Watchung, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Full-Life

China
Category Company
Founded 2021
Sector Life Science
DESCRIPTION

Full-Life is a fully integrated global radiopharmaceutical company with operations in Europe and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. Full-Life was founded in 2021 and is based in Shanghai, China.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal